Stem Cells Make New Muscles. Bodybuildings Next Directions after Peptides & Steroids

Presser

Admin
Staff member
Administrator
[h=1]Stem cells found in blood vessels can help make muscle[/h]

<fieldset class="fieldgroup group-summary" style="padding: 1em; margin: 1em 0px; clear: left; width: 707px; overflow: visible; border: 1px solid rgb(204, 204, 204); "><legend style="padding: 0px; margin: 0px; font-size: 1.7em; font-family: Georgia, 'Times New Roman', Times, serif; letter-spacing: 0px; ">Summary of research</legend>
vessel%20and%20muscle.gif



Research has shown for the first time that a non-muscle type of cell can switch to help make muscle during normal growth. These cells, called pericytes, which are normally found on small blood vessels, were shown to also make both muscle fibres and muscle stem cells. Whilst it has been shown that in extreme situations pericytes can contribute to muscle repair, it was not known whether this was also part of natural muscle growth. This finding is important because it means that normally, there is a signal which ‘tells’ the pericytes to make muscle. We don’t yet know what this signal is but, once we do, it could be used to help repair damaged muscle after injury or disease.



</fieldset>[h=2]What is the idea behind this study?[/h]When muscles are damaged after injury or in disorders such as muscular dystrophy, specialised muscle stem cells or ‘satellite cells’ repair them by making new muscle. This process is called ‘regeneration’. It has recently been shown that during extreme regeneration in muscle, other stem cells have the potential to contribute to muscle repair. It is thought that this could be when the satellite cells are overwhelmed and cannot make enough muscle. One of the other stem cells shown to repair extensively damaged muscle is pericytes.
A pericyte is a type of stem cell which sits wrapped around small blood vessels called capillaries. Capillaries with connected pericytes are found throughout long fibres of muscle tissue providing nutrients and oxygen, and allowing the muscle to function normally. This results in many pericytes being found next to satellite cells inside a muscle.
There are currently no cures for muscular disorders, and a major hope for the future is stem cell therapies. This would involve giving the individual healthy stem cells, which would repair the damaged muscle both immediately, and when future damage occurred.
Although it seems that pericyte cells could have great potential in future therapies, it was not known whether their apparent muscle-making ability was only seen after major injuries, or if it naturally occurred. The idea of this study was to determine whether or not pericytes contribute to normal muscle growth.
[h=2]What did this study show?[/h]In this study, the scientists from San Raffaele Scientific Institute, Milan followed a subset of pericytes producing a protein called Alkaline phosphatase (AP) in mice. To see these cells easily, they marked the AP-producing cells. Straight after marking, these cells were only found around the blood vessels. This proved that they were marking cells which weren’t originally found in the muscle tissue.
To see whether the AP producing pericytes helped to make muscle during growth, they marked the AP-producing pericytes of young mice and waited until adulthood. They saw that over time muscle fibres and satellite cells also became marked. This meant that the marked pericytes were able to change the type of cells they were to become muscle and muscle-specific stem cells. When they did the same experiment in fully grown mice, hardly any muscle became marked, which showed that during maintenance the pericytes weren’t required. They also noticed that when muscles were regenerating, after injury or in a model of Duchenne muscular dystrophy, the number of marked muscle fibres increased.
The researchers tested the muscle-making potential of the switched pericytes by culturing them in a laboratory. They saw that 30% of cells spontaneously made muscle, and that they behaved as normal satellite cells.
These experiments show that there is a balance. During normal maintenance, the satellite cells alone repair damaged muscle. However, when lots of muscle is required – during growth and major repair – AP-producing pericytes help satellite cells to make extra muscle.
[h=2]What does this mean for patients?[/h]Transplanting healthy muscle-making stem cells in the clinic has great potential, but there are several hurdles to overcome. The current issue with the main muscle stem cell – satellite cells – is how to put them into a patients muscle. If they are injected into the bloodstream, they do not efficiently travel to affected muscles. Therefore satellite cells need to be injected into each affected muscle, which is not very efficient. The benefit of using pericytes is that being a blood vessel-associated cell, they can be injected into the blood and find damaged muscle. In fact, human clinical trials in Italy have already started where they are injecting healthy mesoangioblasts, the in vitro expanded cell population derived from pericytes into boys with Duchenne muscular dystrophy (DMD). However, this is at the stage where they are testing the safety of this, and it will be several years until this is completed.
The knowledge from this paper that pericytes normally contribute to muscle growth and the satellite cell population is very important, especially as it showed for the first time that AP-producing pericytes in growing mice switched cell-type to become satellite cells. It is not known what ‘told’ the cells to switch, but finding this out would be valuable for future clinical applications. This is because once we know what this signal is, scientists could use it to maximise the muscle-making potential of pericytes. An example of this would be in muscular dystrophy, where the individual’s satellite cells do not function correctly, so cannot repair damaged muscle. Healthy pericytes could be given the signal to become satellite cells before being injected. Once they travel to the damaged muscles, as well as repairing them, they could provide a new population of satellite cells to repair future damage. This would increase the efficiency of the therapy, providing that it is safe.




 
[h=1]Muscle repair and regeneration: stem cells, scaffolds, and the contributions of skeletal muscle to amphibian limb regeneration.[/h]
Milner DJ[SUP]1[/SUP], Cameron JA.
[h=3]Author information[/h]

[h=3]Abstract[/h]<abstracttext>Skeletal muscle possesses a robust innate capability for repair of tissue damage. Natural repair of muscle damage is a stepwise process that requires the coordinated activity of a number of cell types, including infiltrating macrophages, resident myogenic and non-myogenic stem cells, and connective tissue fibroblasts. Despite the proficiency of this intrinsic repair capability, severe injuries that result in significant loss of muscle tissue overwhelm the innate repair process and require intervention if muscle function is to be restored. Recent advances in stem cell biology, regenerative medicine, and materials science have led to attempts at developing tissue engineering-based methods for repairing severe muscle defects. Muscle tissue also plays a role in the ability of tailed amphibians to regenerate amputated limbs through epimorphic regeneration. Muscle contributes adult stem cells to the amphibian regeneration blastema, but it can also contribute blastemal cells through the dedifferentiation of multinucleate myofibers into mononuclear precursors. This fascinating plasticity and its contributions to limb regeneration have prompted researchers to investigate the potential for mammalian muscle to undergo dedifferentiation. Several works have shown that mammalian myotubes can be fragmented into mononuclear cells and induced to re-enter the cell cycle, but mature myofibers are resistant to fragmentation. However, recent works suggest that there may be a path to inducing fragmentation of mature myofibers into proliferative multipotent cells with the potential for use in muscle tissue engineering and regenerative therapies.</abstracttext>

 
By Matt Canham

I'm sure you've already heard about Stem Cells. Maybe you saw a news story or a read a news article or saw the Presidential address. They are the most widely publicized scientific discovery today and with good reason. How about Embryonic Stem Cells? They have created a great deal of controversy and with good reason. The lure of what Embryonic Stem Cells can do for our health has led to ethical issues surrounding such things as embryo harvesting. One thing remains, Stem Cells represent the future of Health and Wellness as we know it. And they are here to stay.

So what are they?

Stem Cells are master cells, meaning that they can generate many, if not all, of the different tissues of the body. They are with us our entire lives and are released naturally from the bone marrow, but like everything else, the process behind their release slows down with age. When there aren't as many stem cells in the blood stream, the body can't repair and renew itself as it once did. These master cells are still contained in the bone marrow in the millions, just not being released as they should.

As this natural release occurs we need to concern ourselves with finding ways to reverse it. The good news is there are 4 things we can do.

Exercise - as we already know, regular exercise is vital to good health
Proper breathing - deep breathing oxygenates the blood and tissues
Good Nutrition - we need nutrients to nourish and water to flush toxins from our cells
Stem cell enhancers - a new product category set to become what antioxidants are today

Stem Cells are the only known source for rebuilding the body and renewing health by restoring lost or degraded cells. They have already been used to help treat things such as Leukemia, AIDS, Alzheimer's Disease and multiple sclerosis.

They have been used to form new cartilage, grow new corneas to restore sight to the blind, as treatments for stroke victims, and several groups are using adult stem cells with patients to repair damage after heart attacks.

Early clinical trials have also shown initial success in patient treatments for Parkinson's disease and spinal cord injury. And, the first FDA-approved trial to treat juvenile diabetes in human patients is ready to begin at Harvard Medical School, using adult stem cells. In short, they are the building blocks of life itself.

Adult versus Embryonic Stem Cells.

Adult Stem Cells is the term given to stem cells after birth which means babies have adult stem cells in their bodies. Embryonic stem cells are simply those from embryos -- undifferentiated, or not developed into a specific cell types. Research has shown that embryonic stem cells can develop genetic abnormalities. This is not the case with our own adult stem cells.

For this reason, researchers such as Kursad Turksen in his book 'Adult Stem Cells' offer the following wisdom: "Adult stem cell biology is at the forefront of the emerging field of regenerative medicine, offering a source of cells to generate tissues that lack some of the ethical and political impediments inherent in embryonic, fetal, and cloned cells."

The biggest advantage of using adult stem cells is that the body's own stem cells can be used, effectively removing the problems of immune rejection or abnormalities.

Adult stem cell science is real.

Adult stem cell research offers the best and clinically proven treatments for a whole host of human diseases and conditions and is helping people overcome these health challenges as you read this article. There are currently over 700 FDA approved clinical trials going on in the United States using adult stem cells but none for embryonic stem cells which is why the future of regenerative health and wellness looks great with Adult stem cells.

Adult stem cells and athletic performance.

The first question many athletes would ask is this: if I am already healthy, then why would I need more stem cells in my blood stream? When an athlete goes through daily training with maximum effort, numerous microscopic lesions take place in muscles, tendons and ligaments. The result is discomfort and restricted movement in the muscles to prevent any further lesions. Of course, over training results in even further discomfort and the end result is chronic situation that prevents optimal training.

As stem cells migrate into the muscle and become new muscle cells, they accelerate the process of recovery after intense workouts. As a consequence, the muscles may be better prepared for extra workout and the person may be able to exercise to a greater extent.

For people with health challenges, elite athletes and any normal functioning person interested in maintaining optimal health, an increase in Adult stem cells from the bone marrow represents the best way to do this on a consistent basis.
 
[h=1]Researchers discover new way to make muscle cells from human stem cells[/h]
by.. David Tenenbaum

As stem cells continue their gradual transition from the lab to the clinic, a research group at the University of Wisconsin-Madison has discovered a new way to make large concentrations of skeletal muscle cells and muscle progenitors from human stem cells.
The new method, described in the journal Stem Cells Translational Medicine, could be used to generate large numbers of muscle cells and muscle progenitors directly from human pluripotent stem cells. These stem cells, such as embryonic (ES) or induced pluripotent stem (iPS) cells, can be made into virtually any adult cell in the body.
suzuki_muscle_cellESC.jpg

Muscle cells are stained green in this micrograph of cells grown from embryonic stem cells. Cell nuclei are stained blue; the muscle fibers contain multiple nuclei.
Image: Masatoshi Suzuki

Adapting a method previously used to make brain cells,Masatoshi Suzuki, an assistant professor of comparative biosciences in theSchool of Veterinary Medicine, has directed those universal stem cells to become both adult muscle cells and muscle progenitors.
Importantly, the new technique grows the pluripotent stem cells as floating spheres in high concentrations of two growth factors, fibroblast growth factor-2 and epidermal growth factor. These growth factors "urge" the stem cells to become muscle cells.
"Researchers have been looking for an easy way to efficiently differentiate stem cells into muscle cells that would be allowable in the clinic," says Suzuki. The novelty of this technique is that it generates a larger number of muscle stem cells without using genetic modification, which is required by existing methods for making muscle cells.
"Many other protocols have been used to enhance the number of cells that go to a muscle fate," says co-author Jonathan Van Dyke, a post-doctoral fellow in Suzuki’s laboratory. "But what's exciting about the new protocol is that we avoid some techniques that would prohibit clinical applications. We think this new method has great promise for alleviating human suffering."
msuzuki.jpg

Masatoshi Suzuki

Last year, Suzuki demonstrated that transplants of another type of human stem cells somewhat improved survival and muscle function in rats that model amyotrophic lateral sclerosis (ALS). Also known as Lou Gehrig's disease, ALS destroys nerves and causes a loss of muscle control. The muscle progenitors generated with Suzuki’s new method could potentially play a similar role but with enhanced effect.
The new technique can also be used to grow muscle cells from iPS cells from patients with neuromuscular diseases like ALS, spinal muscular atrophy and muscular dystrophy. Thus, the technique could produce adult muscle cells in a dish that carry genetic diseases. These cells could then be used as a tool for studying these diseases and screening potential drug compounds, says Suzuki. "Our protocol can work in multiple ways and so we hope to provide a resource for people who are exploring specific neuromuscular diseases in the laboratory."
 
I follow biotech stocks and came across this press release by a company called Neuralstem.
Neuralstem inc. completed a trial of spinal cord derived neural stem cells for the treatment of amyotrophic lateral sclerosis(Lou Gehrig's disease). The study was done at the neurological dept. of the Massachusetts general hospital. The therapy involves transplanting NSI-566 stem cells directly into specific segments of the spinal cord where the cells integrate into the host motor neurons. They were able to dose up to 16 million cells in 40 injections. That was the maximum tolerated dose and was well tolerated by the patients. Muscle function and lung function was improved after 9 months of treatment. They said we believe the data will support a method of differentiating responders from non-responders.

It looks like this kind of stem cell therapy is both complicated and expensive.
 
Back
Top